KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cvs Health (CVS) EPS (Weighted Average and Diluted) (2016 - 2025)

Cvs Health's EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $2.32 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 77.1% year-over-year to $2.32, compared with a TTM value of $1.4 through Dec 2025, down 61.85%, and an annual FY2025 reading of $1.39, down 62.02% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $2.32 at Cvs Health, up from -$3.13 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $2.32 in Q4 2025, with the low at -$3.13 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is $1.04, with a median of $1.44 recorded in 2024.
  • Year-over-year, EPS (Weighted Average and Diluted) surged 167.57% in 2023 and then crashed 4571.43% in 2025.
  • Tracing CVS's EPS (Weighted Average and Diluted) over 5 years: stood at $1.04 in 2021, then skyrocketed by 70.19% to $1.77 in 2022, then decreased by 10.17% to $1.59 in 2023, then dropped by 17.61% to $1.31 in 2024, then skyrocketed by 77.1% to $2.32 in 2025.
  • Per Business Quant, the three most recent readings for CVS's EPS (Weighted Average and Diluted) are $2.32 (Q4 2025), -$3.13 (Q3 2025), and $0.8 (Q2 2025).